108176-78-9 Usage
Class
N-arylamides
Urea Derivative
Yes
The compound is derived from urea, which is a common structural motif in many pharmaceuticals and agrochemicals.
Benzothiazine Ring System
Present
The compound contains a benzothiazine ring, which is a fused ring system consisting of a benzene ring and a thiazine ring.
Application
Medicinal and Pharmaceuticals
It is used in the field of medicinal and pharmaceuticals, indicating its potential for therapeutic use.
Antimicrobial Agent
Yes
The compound exhibits antimicrobial properties, making it useful in inhibiting the growth of microorganisms.
Therapeutic Properties
Potential
Due to its antimicrobial activity, the compound has potential therapeutic properties for treating microbial infections.
Research and Development
Drug Discovery and Treatment of Microbial Infections
Its molecular structure and properties make it a subject of interest for further research and development in the field of drug discovery and treatment of microbial infections.
Molecular Structure
Complex
The compound has a complex molecular structure, which contributes to its unique properties and potential applications.
Stereochemistry
(3E)-4-methyl-2H-1,4-benzothiazin-3(4H)-ylidene
The compound has a specific stereochemistry, with the E configuration at the 3-position and a 4-methyl substituent on the benzothiazine ring.
Check Digit Verification of cas no
The CAS Registry Mumber 108176-78-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,8,1,7 and 6 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 108176-78:
(8*1)+(7*0)+(6*8)+(5*1)+(4*7)+(3*6)+(2*7)+(1*8)=129
129 % 10 = 9
So 108176-78-9 is a valid CAS Registry Number.
108176-78-9Relevant articles and documents
Synthesis and Biological Activity of Some New N-(2H-1,4-benzoxazin- and benzothiazin-3-yl)-N'-arylureas
Shridhar, D. R.,Sastry, C. V. Reddy,Bansal, O. P.,Rao, P. Pulla
, p. 874 - 876 (2007/10/02)
A series of new N-(2H-1,4-benzoxazin- and benzothiazin-3-yl)-N'-arylureas (IV) and N-(4-methyl-2H-1,4-benzothiazinylidin-3-yl)-N'-arylureas (V) have been synthesised and screened for antiinflammatory, CNS, anthelmintic, antiprotozoal and antimicrobial activities.Some of the compounds possess a low order of antiinflammatory and mild CNS depressant activities.
